Antineoplastic agents 337. Synthesis of dolastatin 10 structural modifications

Area of Science:

• Marine natural products chemistry
• Medicinal chemistry
• Cancer biology

Background:

• Dolastatin 10 is a potent marine-derived peptide with anticancer properties.
• Its mechanism of action involves inhibiting tubulin polymerization, crucial for cell division.
• Structural modifications are explored to enhance efficacy and develop novel therapeutic agents.

Purpose of the Study:

• To synthesize novel structural analogs of dolastatin 10.
• To evaluate the anticancer activity of these analogs against various cancer cell lines.
• To investigate the structure-activity relationships (SAR) of these modifications, particularly concerning tubulin polymerization inhibition.

Main Methods:

• Synthesis of new dolastatin 10 derivatives.
• Anticancer cell line screening to assess cytotoxicity.
• In vitro tubulin polymerization assays to determine inhibitory potential.

Main Results:

• Several structural modifications of dolastatin 10 were successfully synthesized and tested.
• Key structure-activity relationships were identified, revealing critical components for biological activity.
• Replacing the dolaphenine unit with phenethylamine yielded auristatin PE (peptide 11C), demonstrating comparable inhibition of cancer cell growth and tubulin assembly to dolastatin 10.

Conclusions:

• The dolaphenine moiety in dolastatin 10 can be effectively substituted with phenethylamine.
• Auristatin PE represents a promising simplified analog of dolastatin 10 with potent anticancer and anti-tubulin activity.
• These findings provide a basis for the development of new dolastatin 10-based anticancer agents.